Advisors Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Advisors Capital Management's NVO Position: Q2 2026 in Review
Advisors Capital Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 5,635 shares — an estimated $207K sold.
Advisors Capital Management first reported a position in NVO in Q1 2022 and held it in 17 quarters. The position peaked at $1.69M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Advisors Capital Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Advisors Capital Management sold 5,635 Novo Nordisk shares in Q2 2026, an estimated $207K.
- Advisors Capital Management first reported a position in Novo Nordisk in Q1 2022 and held it in 17 quarters.
- Advisors Capital Management's Novo Nordisk position peaked at $1.69M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.